Error in Diagnose of Cancer or Cancer Treatment Negligence

New York Health Care & Failure to Diagnose Cancer

About Risks of Chemotherapy

There are standards and most doctors follow these cancer treatment it may be possible your doctor has neglected your cancer treatment or misdiagnosed your cancer. Treatments may have been to long in the follow up cycles or waiting periods your doctor had may have been negligent waiting periods.  After recieving your correct medical care contact our law offices to see what legal recourses are. 

Cancer patients and their loved ones face many unknowns. Some people find it easier to cope when they know the statistics. Other people find statistical information confusing and frightening, and they think it is too impersonal to be of use to them. The doctor who is most familiar with a patient’s situation is in the best position to discuss the prognosis and to explain what the statistics may mean for that person. At the same time, it is important to understand that even the doctor cannot tell exactly what to expect. In fact, a person’s prognosis may change if the cancer progresses, or if treatment is successful.

A sample of some cancer cases below that may have been misdiagnosed

stage II endometrial cancer Cancer has spread from the uterus to the cervix, but not beyond the cervix. Stage II is divided into stages IIA and IIB, based on how far the disease has spread into the cervix.

stage II esophageal cancer Stage II is divided into stage IIA and stage IIB, depending on where the cancer has spread. In stage IIA, cancer has spread to the layer of esophageal muscle or to the outer wall of the esophagus. In stage IIB, cancer may have spread to any of the first three layers of the esophagus and to nearby lymph nodes.

stage II gastric cancer Cancer has spread (1) completely through the mucosal (innermost) layer of the stomach wall and is found in 7 to 15 lymph nodes near the tumor, or (2) to the muscularis (middle) layer of the stomach wall and is found in up to 6 lymph nodes near the tumor, or (3) to the serosal (outermost) layer of the stomach wall but not to lymph nodes or other organs.

stage II hypopharynx cancer Cancer that involves more than one area of the hypopharynx or is between 2 and 4 centimeters (between 0.75 and 1.5 inches).

stage II kidney cancer Tumor that is larger than 7 centimeters (2.75 inches).

stage II laryngeal cancer Cancer that is found in the larynx only and has not spread to lymph nodes in the area or to other parts of the body. The exact definition of stage II depends on whether the cancer started in the supraglottis (cancer is in more than one area of the supraglottis, but the vocal cords can move normally); the glottis (cancer has spread to the supraglottis, the subglottis, or both, and the vocal cords may not be able to move normally); or the subglottis (cancer has spread to the vocal cords, which may not be able to move normally).

Chemotherapy
With regard to chemotherapy, patient age is an important factor and the possibility of gonadal recovery improves with the length of time off chemotherapy. The germinal epithelium of the adult testis is more susceptible to damage than that of the prepubertal testis.[1] The evidence to date (largely from adjuvant studies) suggests that patients older than 35 to 40 years of age are most susceptible to the ovarian effects of chemotherapy. The ovaries of younger women can tolerate greater doses.[2] Predicting the outcome for any individual patient is difficult as the course of ovarian functioning following chemotherapy is variable.[1] Relative risk of ovarian failure and testicular damage from cytotoxic agents has been studied, and the alkylating agents have subsequently been shown to be damaging to fertility. The following agents have been shown to be gonadotoxic: busulfan, melphalan, cyclophosphamide, nitrosoureas, cisplatin, chlorambucil, mustine, carmustine, lomustine, cytarabine, ifosfamide, and procarbazine.[1,3-6]

Chemotherapy regimens for the treatment of non-Hodgkin’s lymphoma are generally less gonadotoxic than those used for Hodgkin’s lymphoma.[1] The effects of chemotherapy on testicular function has also been widely studied in patients with testicular cancer. A recent review reported that more than half of the patients with testicular germ-cell cancer showed impaired spermatogenesis before undergoing cytotoxic treatment. Permanent infertility is ultimately defined by dose of cisplatin in these patients. At doses below 400 mg/m2, long-term effects on endocrine function and sperm production are unlikely to occur. Higher doses should be expected to cause long-term endocrine-gonadal dysfunction.[7]

read more about NY cancer & failure to diagnose cancer